Bai, Q., Liu, L., Xia, Y., Wang, J., Xi, W., Qu, Y., . . . Guo, J. (2017). IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma. Oncotarget.
シカゴスタイル引用形Bai, Qi, et al. "IRF5 Is Associated With Adverse Postoperative Prognosis of Patients With Non-metastatic Clear Cell Renal Cell Carcinoma." Oncotarget 2017.
MLA引用形式Bai, Qi, et al. "IRF5 Is Associated With Adverse Postoperative Prognosis of Patients With Non-metastatic Clear Cell Renal Cell Carcinoma." Oncotarget 2017.
警告: この引用は必ずしも正確ではありません.